Theodore Reiss, MD, MBE EVP and Chief Medical Officer
As Executive Vice President and Chief Medical Officer, Ted is responsible for developing, accelerating and executing the company’s clinical development portfolio, and providing medical expertise in decisions affecting the company’s clinical development programs. He oversees Clinical Program Management, Clinical Research, Clinical Operations and Regulatory.
Ted was most recently a Venture Partner at Novo Ventures and previously at Celgene, where he led Clinical Research and Development, Inflammation and Immunology. He also has held global leadership positions in drug development at Novartis, Covance, and Merck. He has also served as Research Professor of Medicine at the Vanderbilt University School of Medicine. A graduate of the University of Pennsylvania, Ted earned his medical degree at Vanderbilt, and received a graduate degree in Bioethics from Penn.